PL Voices
31 - 45 of
57 Results
Sort Results:
Article:
how to manage osteoporosis when patients don't get enough benefit from a bisphosphonate
October 2013
Article:
STOPPING bisphosphonates (alendronate, etc) after 3 to 5 years in patients at low fracture risk
July 2013
Guideline:
2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia
December 2012